Israel Rubinstein
Corporate Officer/Principal chez University of Illinois
Profil
Israel Rubinstein is a Professor at the University of Illinois since 1993.
He was a Director at Advanced Life Sciences Holdings, Inc. from 2001 to 2011.
He holds a doctorate degree from The Hebrew University of Jerusalem.
Postes actifs de Israel Rubinstein
| Sociétés | Poste | Début |
|---|---|---|
| University of Illinois | Corporate Officer/Principal | 04/01/2010 |
Anciens postes connus de Israel Rubinstein
| Sociétés | Poste | Fin |
|---|---|---|
| ADVANCED LIFE SCIENCES HOLDINGS, INC. | Directeur/Membre du Conseil | 05/05/2011 |
Formation de Israel Rubinstein
| The Hebrew University of Jerusalem | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Advanced Life Sciences Holdings, Inc.
 Advanced Life Sciences Holdings, Inc. BiotechnologyHealth Technology Advanced Life Sciences Holdings, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of novel drugs in therapeutic areas of infection, cancer and inflammation. Its product candidate, Restanza, is a novel once-a-day oral antibiotic in late-stage development for the treatment of life-threatening infections including community-aquired bacterial pneumonia and biodefense pathogens including anthrax, plague and tularemia. The company was founded by Michael T. Flavin on January 1, 1999 and is headquartered in Woodridge, IL. | Health Technology |
